Abstract
The main problem of diagnosis and treatment of haemangiomas and of vascular system defects is the lack of unified classification, systemised for all the specialists dealing with this issue. Existing histopathological and clinical classifications are inconsistent, often overusing the term haemangioma which is an infancy tumour. This can lead to an incorrect diagnosis which affects the course of the illness and the treatment. In this paper the authors describe the recommended classification of the International Society for the Study of Vascular Anomalies (ISSVA), and compare it with histopathological classification of vascular tumours by WHO, and soft tissue tumour classification by the Association of Clinical Oncology. Furthermore, current methods of diagnosing vascular tumours and malformations are also discussed, with specific consideration of histopathological imaging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
